INMUNE BIO INC. Prepaid Expense, Current
INMUNE BIO INC. (INMB) had Prepaid Expense, Current of $132.00 million as of 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-10-30
- 2025-09-30: Prepaid Expense, Current $132.00M.
- 2024-09-30: Prepaid Expense, Current $252.00M.
- 2023-06-30: Prepaid Expense, Current $30.00K.
- 2023-03-31: Prepaid Expense, Current $3.63M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2025-09-30 | $132.00M 10-Q · filed 2025-10-30 | |
| 2024-09-30 | $252.00M 10-Q · filed 2025-10-30 | |
| 2023-06-30 | $30.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $3.63M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $34.00K 10-Q · filed 2023-08-07 | $4.03M 10-K · filed 2023-03-02 |
| 2022-09-30 | $4.60M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $4.22M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $4.67M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.28M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $1.30M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.40M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.51M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $220.00K 10-K · filed 2022-03-03 | $220.09K 10-K · filed 2021-03-04 |
| 2020-09-30 | $216.87K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $342.49K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $266.44K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $97.62K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $122.03K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $200.02K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $275.77K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $15.55K 10-K · filed 2020-03-11 | |
| 2017-12-31 | $42.65K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |